NSE · ANUHPHR
Anuh Pharma Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,603
of 5,072 stocks
▼ 91W
Peak #1,594 · 21 Sep 2026
Operating in Healthcare, Anuh Pharma Limited remains firmly promoter-controlled, with promoters holding 72%, is growing revenue at a solid clip, and trades at a moderate earnings multiple.
Market Cap
906.23 Cr
P/E Ratio
22.05
P/B Ratio
2.57
ROE
11.65%
ROCE
15.43%
Dividend Yield
1.66%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 193.81 Cr | 202.12 Cr | 197.18 Cr | 185.88 Cr |
| Net Profit | 11.42 Cr | 11.68 Cr | 13.45 Cr | 7.61 Cr |
| EPS | 1.14 | 1.17 | 1.34 | 0.76 |
| Operating Profit | 16.93 Cr | 15.63 Cr | 17.91 Cr | 10.00 Cr |
Shareholding pattern
Promoter
71.80%
Public
28.20%
Mutual fund holdings
₹0.01
Cr total
2
Schemes
2
Fund Houses
₹0.01 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.01 Cr (64.9%)
Bandhan Mutual Fund₹0.00 Cr (35.1%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 05 Aug 2026 | Dividend | Dividend - Rs 1.50 Per Share |
| 14 Aug 2025 | Dividend | Dividend - Rs 1.50 Per Share |
| 15 Jul 2025 | Bonus | Bonus 1:1 |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.